MedWatch

Juan Jose Gonzalez, CEO of Ambu | Foto: Ambu/PR

Tough competition forces innovation at Ambu

Ambu is intensifying its efforts to create the next generation of its duodenoscopes. A number of competitors are circling, and an upcoming tender is a good opportunity for income. CEO Juan Jose Gonzalez calls the new duodenoscope the biggest earner of the future.

Foto: Bose / PR

Analyst on new Bose hearing aid: "Won't disrupt Danish manufacturers"

US electronics company Bose's announced launch of a new, cheap self-tuning hearing aid won't cause sales to plummet for established hearing aid manufacturers, analysts believe. Demant welcomes the competition and WSA plans to test Bose's new solution to understanding its technology.

Lundbeck loses top-line terrain but surpasses expectations

Sales of the drug Northera, which is no longer protected by patents, plummeted in Lundbeck's first quarter, while most other key products surpassed analysts' forecasts. This means the firm brought in more revenue than the market expected.

GN executive does not envy sister firm's booming success

The tables have turned at GN Store Nord as the headset division GN Audio has now surpassed the GN Hearing business leg for several quarters. The chief of the latter, Gitte Aabo, is hardly concerned by this development as she sees it as an advantage to have a successful sister under the same parent company.

Financial director Anders Lonning-Skovgaard | Foto: Niels Hougaard/ERH

Covid-19 costs Coloplast USD 33m in extended court cases

Medtech company Coloplast has set aside a further USD 33m to pay for compensation in the remaning cases over its vaginal mesh product in the US. The covid-19 crisis has delayed court cases and increased the cost of legal counsel, but the financial director expects this amount to be enough to but the cases behind them.

Leo Pharma's board chair steps down

Olivier Bohuon, the chair of Leo Pharma's board of directors, is resigning from his position due to personal reasons. The search for his replacement is now underway.

Latest news

See all jobs